Neuren Pharmaceuticals Limited(ASX:NEU) dropped from S&P/ASX Emerging Companies Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.25 AUD | +3.22% | -0.16% | -22.91% |
Apr. 24 | Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments | MT |
Apr. 23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.91% | 1.55B | |
+26.77% | 661B | |
+27.43% | 566B | |
-6.29% | 352B | |
+20.39% | 332B | |
+3.11% | 283B | |
+13.96% | 231B | |
+5.16% | 200B | |
-9.04% | 195B | |
-4.91% | 145B |
- Stock Market
- Equities
- NEU Stock
- News Neuren Pharmaceuticals Limited
- Neuren Pharmaceuticals Limited(ASX: NEU) dropped from S&P/ASX Emerging Companies Index